Viewing Study NCT03694132


Ignite Creation Date: 2025-12-24 @ 9:45 PM
Ignite Modification Date: 2026-01-03 @ 11:44 PM
Study NCT ID: NCT03694132
Status: COMPLETED
Last Update Posted: 2025-11-18
First Post: 2018-09-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Brain Excitability and Connectivity in Sensory-motor Pathways in ALS
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
Organization:

Study Overview

Official Title: Evaluation and Characterization of Infraclinical Sensory Deficits in Amyotrophic Lateral Sclerosis by Brain Imaging and Electrophysiology
Status: COMPLETED
Status Verified Date: 2021-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SOM_ALS
Brief Summary: The main objective is to determine the origin of somatosensory alteration in patients with ALS and to evaluate its impact on brain activity by coupling different imaging modalities and indirect electrophysiology.

The secondary objective is to evaluate whether the observed functional changes in MEG / EEG and functional MRI correlate with structural lesions revealed with diffusion MRI (anatomo-functional connectivity of the brain).
Detailed Description: Somatosensory evoked potentials (SEPs) produced by ulnar nerve electrical stimulation will be collected with combined MEG and EGG.

Functional MRI will be performed during electrical stimulation of ulnar nerve and during mechanical vibration of ADM tendon.

Brain diffusion MRI will be performed. Anatomical MRI will be done for source location. Brain resting state activity will be recorded with MEG/EEG and fMRI.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: